Status and phase
Conditions
Treatments
About
This study will assess the bioavailability of aliskiren and valsartan as a single tablet compared to the same doses of the two drugs given as two separate tablets in healthy subjects.
Sex
Ages
Volunteers
Inclusion criteria
and all female subjects must have negative pregnancy results at screening and each baseline (regardless of reported reproductive status).
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria may apply
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal